Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">AP 12009: Completed Phase IIb enrollment</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Antisense completed enrollment of over 140 patients in an international Phase IIb trial. ......

AP 12009: Completed Phase IIb enrollment

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home